Sanochemia submits a marketing authorization application (MAA) for Ferumoxtran under the decentralized procedure. The USPIO-based MRI contrast agent is intended for the detection and characterization of lymph node metastases in prostate cancer patients.
WeiterlesenIn October 2025, Sanochemia Pharmazeutika was honored with the Austrian Leading Companies (ALC) Inclusion Award. This recognition highlights the company’s longstanding commitment to fostering diversity, equal opportunities, and accessibility in the workplace.
WeiterlesenThe multicentric prospective PROSTAPROGRESS study on Ferumoxtran confirmed to meet also secondary endpoints. Post-hoc analysis showed elevated sensitivity and specificity data for metastatic lymph node lesions at levels surpassing the levels of current technologies.
WeiterlesenNeufeld, Austria, February 25th, 2025 – Sanochemia Pharmazeutika today announced positive headline results of the pivotal phase III study PROSTAPROGRESS on Ferumoxtran (EudraCT 2018-004310-18), performed by SPL Medical B.V. (Nijmegen,…
WeiterlesenSanochemia Pharmazeutika continues to strengthen its position in medical imaging with the submission of an application for its liver-specific contrast agent in multiple European countries.
WeiterlesenThe registration initiative launched by Sanochemia Pharmazeutika in 2021, together with the continuously increasing market demand, has led to a record volume of orders.
WeiterlesenSanochemia Pharmazeutika secures exclusive licensing rights to a new MRI contrast agent based on ferumoxtran, that is in an advanced pivotal trial in clinical phase III and may be used to detect the smallest lymph node metastases in prostate cancer patients. The product is already deployed in the Netherlands within an authorized Named-Patient-Use-Program (Artsenverklaring).
WeiterlesenSanochemia Pharmazeutika is strengthening its position in the field of medical imaging with an exclusive product license for a MRI contrast agent based on iron-containing nanoparticles under the brand name Resotran®.
WeiterlesenSanochemia Pharmazeutika is taking the green transition as an opportunity and takes a leap towards sustainability with a new photovoltaic (PV) facility.
WeiterlesenFor Sanochemia, joint development with employees is an important cornerstone of entrepreneurial activities. It is therefore particularly gratifying that some of Sanochemia's apprentices were honored for their special achievements: In…
Weiterlesen
